Metraipolis › archive › dc_ecdc6c480ca7

Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence — Europe PMC PMID:41598512

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41598512
DOI: 10.3390/jcm15020574
License (as archived): solo-consultazione
Archived: 2026-11-06T22:20:32.795Z
SHA-256 of the archived text: 6b21dcead80dad5c59925a841d3b19ca4822c1fc4a1d3436b9d74ebf4d419bce
Stable URL of this page: https://metraipolis.com/documento/dc_ecdc6c480ca7

How to cite

Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence — Europe PMC PMID:41598512 — Europe PMC (en), https://europepmc.org/article/MED/41598512 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecdc6c480ca7 (Metraipolis archive dc_ecdc6c480ca7, sha256 6b21dcead80dad5c59925a841d3b19ca4822c1fc4a1d3436b9d74ebf4d419bce)

BibTeX

@misc{dcecdc6c480ca7,
  title = {Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence — Europe PMC PMID:41598512},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598512},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecdc6c480ca7; sha256 6b21dcead80dad5c59925a841d3b19ca4822c1fc4a1d3436b9d74ebf4d419bce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598512. Agents can read the archived copy with the MCP tool read_document.